Assignee
SEQUENTA INC
US·3 granted patents·13 pending applications·136 citations·filing 2012–2014
Top patents by PatentIndex Score
16 records- 0197US9228232B2Methods of monitoring conditions by sequence analysisSEQUENTA INC·Filed 2014·Granted Jan 5, 2016·66 cites·23 claims
- 0296US9416420B2Monitoring health and disease status using clonotype profilesSEQUENTA INC·Filed 2013·Granted Aug 16, 2016·47 cites·19 claims
- 0393US9394567B2Detection and quantification of sample contamination in immune repertoire analysisSEQUENTA INC·Filed 2013·Granted Jul 19, 2016·23 cites·8 claims
- 0474US2013344066A1Methods of monitoring conditions by sequence analysisSEQUENTA INC·Filed 2013·Application pending·0 cites
- 0557US2015252422A1T-cell receptor clonotypes shared among ankylosing spondylitis patientsSEQUENTA INC·Filed 2012·Application pending·0 cites
- 0652US2016115532A1High sensitivity mutation detection using sequence tagsSEQUENTA INC·Filed 2013·Application pending·0 cites
- 0752US2015247198A1Monitoring clonotypes of plasma cell proliferative disorders in peripheral bloodSEQUENTA INC·Filed 2013·Application pending·0 cites
- 0851US2015299800A1Monitoring mantle cell lymphoma clonotypes in peripheral blood after immunotransplantSEQUENTA INC·Filed 2013·Application pending·0 cites
- 0951US2014349883A1Monitoring transformation of follicular lymphoma to diffuse large b-cell lymphoma by immune repertoire analysisSEQUENTA INC·Filed 2012·Application pending·0 cites
- 1050US2014336059A1Clonotypes as biometric specimen tagsSEQUENTA INC·Filed 2012·Application pending·0 cites
- 1150US2014234835A1Rare clonotypes and uses thereofSEQUENTA INC·Filed 2014·Application pending·0 cites
- 1249US2014342360A1Method of measuring immune activationSEQUENTA INC·Filed 2012·Application pending·0 cites
- 1349US2015031553A1Method of measuring immune activationSEQUENTA INC·Filed 2012·Application pending·0 cites
- 1445US2015038346A1Monitoring immune responsiveness to cancer vaccinationSEQUENTA INC·Filed 2013·Application pending·0 cites
- 1542US2014256592A1Determining responsiveness of autoimmune patients to dmard treatmentSEQUENTA INC·Filed 2012·Application pending·0 cites
- 1642US2015275308A1Monitoring diffuse large b-cell lymphoma from peripheral blood samplesSEQUENTA INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SEQUENTA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →